| Literature DB >> 28320193 |
Roland Sauer1, Philipp Gölitz2, Johannes Jacobi3, Stefan Schwab1, Ralf A Linker1, De-Hyung Lee4.
Abstract
Progressive multifocal leukoencephalopathy (PML) is a rare, opportunistic and often fatal disease of the CNS which may occur under immunosuppression in transplant patients. Brain stem PML is associated with a particularly bad prognosis. Here, we present a case of a renal transplant patient treated with mycophenolate mofetil (MMF) and tacrolimus who developed brain stem PML with limb ataxia, dysarthria and dysphagia. Diagnosis was established by typical MRI features and detection of JCV-DNA in the CSF. Immune reconstitution after stopping MMF and tacrolimus led to a complete and sustained remission of symptoms with improvement of the brain stem lesion over a follow-up over 20months. In summary, early detection of PML and consequent treatment may improve neurological outcomes even in brain stem disease with a notorious bad prognosis.Entities:
Keywords: Immunosuppression; Mycophenolate mofetil; Outcome; Polyoma virus; Progressive multifocal leukoencephalopathy; Renal transplantation; Tacrolimus
Mesh:
Substances:
Year: 2017 PMID: 28320193 DOI: 10.1016/j.jns.2017.01.046
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181